These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6203337)
21. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis. Sarwar S; Khan AA; Tarique S J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536 [TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy. Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558 [TBL] [Abstract][Full Text] [Related]
23. Liver Stiffness and Serum Alpha-Fetoprotein in Discriminating Small Hepatocellular Carcinoma from Cirrhotic Nodule. Li JW; Ling WW; Lu Q; Lu CL; He D; Luo Y Ultrasound Q; 2016 Dec; 32(4):319-326. PubMed ID: 27575844 [TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area. Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364 [TBL] [Abstract][Full Text] [Related]
25. [Clinical chemical parameter changes in patients with liver metastases]. Stoĭchev S; K'osovska R; Khaĭdutova R; Dimitrova S; Chakurov S Vutr Boles; 1979; 18(2):45-50. PubMed ID: 37654 [TBL] [Abstract][Full Text] [Related]
26. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma]. Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers. Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164 [TBL] [Abstract][Full Text] [Related]
29. Performance of Alpha Fetoprotein in Combination with Alpha-1-acid Glycoprotein for Diagnosis of Hepatocellular Carcinoma Among Liver Cirrhosis Patients. Gani RA; Suryamin M; Hasan I; Lesmana CR; Sanityoso A Acta Med Indones; 2015 Jul; 47(3):216-22. PubMed ID: 26586387 [TBL] [Abstract][Full Text] [Related]
30. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma. Abbasi A; Bhutto AR; Butt N; Munir SM J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098 [TBL] [Abstract][Full Text] [Related]
31. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Sterling RK; Jeffers L; Gordon F; Venook AP; Reddy KR; Satomura S; Kanke F; Schwartz ME; Sherman M Clin Gastroenterol Hepatol; 2009 Jan; 7(1):104-13. PubMed ID: 18849011 [TBL] [Abstract][Full Text] [Related]
32. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Nomura F; Ohnishi K; Tanabe Y Cancer; 1989 Oct; 64(8):1700-7. PubMed ID: 2477133 [TBL] [Abstract][Full Text] [Related]
33. [Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma]. Jia HL; Xing XJ; Ye QH; Qin LX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):440-3. PubMed ID: 18795617 [TBL] [Abstract][Full Text] [Related]
34. [The significance of the determination of AFP-isoform in the early diagnosis of hepatocellular carcinoma]. Ishizuka H; Arakawa Y; Nakano E Rinsho Byori; 1992 Dec; 40(12):1265-73. PubMed ID: 1284914 [TBL] [Abstract][Full Text] [Related]
35. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging. Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792 [TBL] [Abstract][Full Text] [Related]
36. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis. Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824 [TBL] [Abstract][Full Text] [Related]
37. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis. Fung J; Lai CL; Fong DY; Yuen JC; Wong DK; Yuen MF Liver Int; 2008 Dec; 28(10):1408-16. PubMed ID: 18482268 [TBL] [Abstract][Full Text] [Related]
38. Clinical significance of serum alpha-fetoprotein in patients with liver cirrhosis. Furukawa R; Tajima H; Nakata K; Kono K; Muro T; Sato A; Kawahara K; Ishii N; Kusumoto Y; Munehisa T Tumour Biol; 1984; 5(6):327-38. PubMed ID: 6085599 [TBL] [Abstract][Full Text] [Related]
39. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
40. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]